Clinical trial

Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)

NCT00286169

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-04-01

PhasePHASE3

Study timeline

Study start (unknown)2006-04-01Date precision: month

Registry last updated2022-04-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small-cell Lung Cancerunresolved

Interventions

Amrubicin HydrochlorideDRUG

Sponsors & collaborators

Sumitomo Pharma Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00286169 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.